– USA, IL – Veradigm Inc. (NASDAQ: MDRX) today announced the appointments of Susan Rodriguez and Dr. Shih-Yin Ho (MD) to its Board of Directors, bringing their combined experience in the pharmaceutical industry, digital health, and healthcare to help build upon the vision of transforming health, insightfully.
About Susan Rodriguez
Ms. Rodriguez joins the Veradigm Board with over 30 years of experience in the biopharmaceutical industry, in a broad range of executive leadership roles. She currently serves as CCO at Ardelyx, Inc., where she has been responsible for leading the commercbuild-out out to launch first-in-class medicines into the gastroenterology and nephrology therapeutic segmenBeforer to this, Ms. Rodriguez served as CEO of Tolmar Pharmaceuticals, Inc. a specialty oncology company. In 2019, she was named President of the branded division upon the formation of the global entity, Tolmar, IBeforer to Tolmar, Ms. Rodriguez joined Abbott Laboratories in 1990. She held various leadership positions there until 2014, most recently as Divisional VP of Global Marketing. In addition to her professional experience, she currently serves on the boards of Heron Therapeutics Inc. and Cuba Emprende Foundation, a non-profit organization.
Ms. Rodriguez received both a bachelor’s degree and a master’s degree in Psychology from the University of Pennsylvania.
About Dr. Shih-Yin Ho
Dr. Shih-Yin Ho joins Veradigm’s Board as a seasoned digital health, software, and pharmaceutical services entrepreneur, executive, and advisor, having spent over 20 years developing products and companies in health information infrastructure, data analytics, and decision support for life sciences. Dr. Ho currently serves as CEO and Co-Founder of Last Mile Research, an organization she co-founded in 2021, dedicated to transforming how life science companies source talent for clinical trials. Before this, she served as President of Glimpse LLC, an independent software and strategy consulting firm serving pharmaceutical services companiesBeforeto Glimpse, Dr. Ho held leadership positions with Aetion Inc., a provider of real-world evidence software solutions for life science companies and payers along with two other organizations, Medidata and Pfizer. Dr. Ho was also the Founder & CEO of Context Matters Inc., which was later acquired by Decision Resources Group and then Clarivate PLC. Dr. Ho began her career as an emergency medicine physician before pursuing opportunities in the e-health industry in 1998. Currently, Dr. Ho serves on the board of directors at Genesis Research and PS3til6, a non-profit organization.
She earned her bachelor’s degree from Brown University before completing her M.D. from Yale University School of Medicine and an M.B.A. from Harvard Business School.
About Veradigm
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
For more information: https://veradigm.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
